Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease

Levodopa (LD) is the most effective drug in the treatment of Parkinson’s disease (PD). However, although it represents the “gold standard” of PD therapy, LD can cause side effects, including gastrointestinal and cardiovascular symptoms as well as transient elevated liver enzyme levels. Moreover, LD...

Descripción completa

Detalles Bibliográficos
Autores principales: Bello, Fabio Del, Giannella, Mario, Giorgioni, Gianfabio, Piergentili, Alessandro, Quaglia, Wilma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523988/
https://www.ncbi.nlm.nih.gov/pubmed/30970612
http://dx.doi.org/10.3390/biom9040142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523988/
https://www.ncbi.nlm.nih.gov/pubmed/30970612
http://dx.doi.org/10.3390/biom9040142

Ejemplares similares